Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
299 Leser
Artikel bewerten:
(1)

Atrial Fibrillation Market is expected to generate a revenue of USD 48.82 Billion by 2030, Globally, at 12.3% CAGR: Verified Market Research

The prevalence of obesity and cardiovascular disease is increasing rapidly around the globe. The adoption of an unhealthy and fast-paced lifestyle, increase in the heart disease rapidly, are the factors driving the market for atrial fibrillation.

JERSEY CITY, N.J., Nov. 9, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Atrial Fibrillation Market" By Procedures (Pharmacological Drugs, Non-Pharmacological Treatment), and By Geography.

Verified_Market_Research_Logo

According to an extensive study conducted by Verified Industry Research on the Atrial Fibrillation Market, the market size was valued at USD 17.28 Billion in 2021 and is projected to reach USD 48.82 Billion by 2030, growing at a CAGR of 12.3% from 2022 to 2030.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=31347

Browse in-depth TOC on "Atrial Fibrillation Market"

202 - Pages
126 - Tables
37 - Figures

Global Atrial Fibrillation Market Overview

Atrial fibrillation is a medical condition that arises due to abnormal and faulty electric activities in the atria of the heart. It is a form of cardiac arrhythmia. Generally, atrial fibrillation does not show any symptoms which can be specifically linked with the condition. But in general, it can be identified through symptoms such as fainting, palpitations, congestive heart failure, or chest discomfort. Patients having such symptoms can visit the physician for an ECG which can denote atrial fibrillation. Based on the severity of the condition, it is classified into three categories, severity paroxysmal, persistent, and permanent. WHO has stated atrial fibrillation is the most common form of cardiac arrhythmia. Patients suffering from atrial fibrillation have much higher chances of producing blood clots which could result in a stroke.

With the growth in the geriatric population, the prevalence of atrial fibrillation has gone significantly up. This has created a demand for catheter ablation for cardiac rehabilitation. Because of this, the market for atrial fibrillation has also grown significantly in recent years. During the forecast period, with the perfect balance between medical devices used for atrial fibrillation and medication, the market for atrial fibrillation is expected to grow exponentially.

Additionally, the increased prevalence of strokes, brain damage, and atrial fibrillation caused by blood clots, as well as an expanding elderly population, are driving the expansion of the global Atrial Fibrillation Market. Technological developments in microwave catheter ablation and radiofrequency, as well as the increased prevalence of disorders caused by lifestyle choices like as drinking and smoking, are projected to drive market growth further

Key Players

The major players in the market are AtriCure Inc., Boston Scientific Corporation, Boehringer Ingelheim GmbH, Biosense Webster Inc., St. Jude Medical Inc., Johnson & Johnson Ltd., CardioFocus Inc., Sanofi-Aventis, Endoscopic Technologies Inc., and Bristol-Myers Squibb Corporation.

Verified Market Research has segmented the Global Atrial Fibrillation Market On the basis of Procedures, and Geography.

  • Atrial Fibrillation Market, By Procedures
    • Pharmacological Drugs
      • Anti-arrhythmic Drugs
      • Anti-coagulant Drugs
    • Non-Pharmacological Treatment
      • Catheter Ablation Procedures
      • Radiofrequency
      • HIFU
      • Cryoablation
      • Others
    • Maze Surgery
    • Electric Cardioversion
  • Atrial Fibrillation Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Electrophysiology Devices Market By Product Type (EP Ablation Catheters, EP Diagnostic Catheters), By Indication (Atrial Fibrillation (AF), Wolff-Parkinson-White Syndrome (WPW)), By End-User (Hospitals, Diagnostic Centers), By Geography, And Forecast

Implantable Cardiac Monitor Market By Indication Type (Cardiac Arrhythmias, Atrial Fibrillation, Epilepsy & Unexplained falls), By End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Center & Clinics), By Geography, And Forecast

Atrial Fibrillation Surgery Market By Procedure (Catheter Ablation Procedures, Surgical Ablation/Maze Procedures), By Product (Catheter Ablation Product Market, Surgical Ablation Market), By Geography, And Forecast

Atrial Fibrillation Drugs Market By Product (Antiarrhythmic Drugs, Anticoagulant Drugs), By Type (Paroxysmal, Permanent, Persistent) By Geography, And Forecast

Top Cardiac Catheter Sensor Companies fueling the halted healthcare industry

Visualize Atrial Fibrillation Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us
Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/atrial-fibrillation-market-is-expected-to-generate-a-revenue-of-usd-48-82-billion-by-2030--globally-at-12-3-cagr-verified-market-research-301673237.html

© 2022 PR Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.